Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.
about
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs.Perspective of synaptic protection after post-infarction treatment with statinsEffect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesAtorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathwaysMultifunctional drugs for head injuryAmeliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neuronsSimvastatin enhances hippocampal long-term potentiation in C57BL/6 mice.New directions in the treatment of normal tension glaucoma.Atorvastatin in stroke: a review of SPARCL and subgroup analysis.Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study.Statins and neuroprotection: a prescription to move the field forwardAdministration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy.Protection after stroke: cellular effectors of neurovascular unit integrity.Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells.The parasympathetic nervous system in the quest for stroke therapeuticsStatin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis.Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke.Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease.Nitric oxide: considerations for the treatment of ischemic stroke.The relationship between statin use and open-angle glaucomaCombination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injurySimvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.The basal level of intracellular calcium gates the activation of phosphoinositide 3-kinase-Akt signaling by brain-derived neurotrophic factor in cortical neuronsRosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neuronsStatin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling.Therapeutic modalities in symptomatic intracranial arterial occlusive disease.Simvastatin protects ischemic spinal cord injury from cell death and cytotoxicity through decreasing oxidative stress: in vitro primary cultured rat spinal cord model under oxygen and glucose deprivation-reoxygenation conditionsHypertension, vascular cognitive disorders and neuroprotection.Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.Direct inhibition of retinoic acid catabolism by fluoxetine.Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging.Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma.The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol.Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling.
P2860
Q27300308-A2AA2A59-607F-4F21-9460-38BCE2FEE942Q28080692-F9F41F5A-DE70-476A-A4D2-14B220B6388BQ28220559-B70C2206-5193-430D-ADB9-678DBC1AB4EBQ28388335-0CA3FC61-0976-4CFA-BDFC-F9525DF246AFQ28584332-0CDEC780-0D7C-40E4-AA2B-55472563DD85Q30371428-CDE07DD1-85BB-4447-B19C-FA2491756B78Q33358995-31E053D2-AFBC-493E-8950-DE3F90220256Q33610240-BF206AF8-E83E-42D5-8A75-202A8E80118FQ33665461-D21B64C5-9241-4DFB-BA4F-3BC2C03B2C32Q33665597-FE584C44-E4B0-4DEB-B1E8-E088B1B36C34Q33785942-F31C6176-7F98-48D1-9B89-08E0257523E4Q33797634-2C516083-F40B-4524-A23D-B0D1246FD6C7Q33942386-931A7DAC-59EA-4BD3-9222-8895D2BFC91CQ34015831-B12A85D2-1BB9-4C53-B0B7-A8A563330B50Q34031703-F3581815-DB41-48F2-9461-0C7C9A390916Q34043168-80F6D466-CED8-4BE9-B9FC-36D0BAAAF802Q34081527-E21CD5CF-9D57-4C2A-9DDE-2D13D27EAA8BQ34787972-14CE34D2-E821-468D-81BA-293B89F0FE73Q34997955-08F2900E-8566-4D40-92AB-85BC0EAC0673Q34999332-EF43CA38-4B35-4012-BAB2-36985CCCF90AQ35075417-49BB9AEF-3B9B-4900-AE14-9EA055E588AAQ35634151-BBA81334-CBBD-44ED-9DA7-924346D3F571Q36079329-2CE47BF2-D15B-45D4-8E35-9C3245834602Q36282796-CF0C2EC6-8E8D-4585-B706-0F66BDEED0C0Q36334700-D07DD91D-31D6-4AF9-95EC-9C23B74672F4Q36765017-E73CEA48-E499-440F-B449-E42705DC05CAQ36953203-101CF765-2EDA-4670-AD46-5E985B91DE29Q37086446-9407E277-B2B7-462A-B6D2-1B8617AE2C20Q37377515-E9BDAEF5-4B57-470B-955C-08F318C34315Q37639502-9A8F3ED4-3FF1-4951-B389-67D710142D5EQ37671313-1E03FC11-666B-4C4B-88DB-96C03E725236Q38764910-5020E331-7516-48E1-8BBB-1427E61E0010Q38861519-98F486FD-4432-4157-9B9B-94B3D67D02A9Q38874017-2598714E-9842-4AE8-B42C-217706717DDAQ38921294-F63C5817-0906-4FF9-9417-6CAC9DCDF42FQ38970520-AF8488AE-F518-4EE1-9A5A-6038D6906E1AQ39003992-3642FDDC-B772-442B-9BDF-16FA56E86345Q39348762-79E35D66-9975-43DA-8D5D-E9792E96261DQ39478056-BC0E9DEE-FD6F-42B7-8F46-49FF5C1B95C2Q39846471-CD2FADFA-6633-4E93-990C-A6079F860D8E
P2860
Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Neuroprotective effects of ato ...... in primary cortical neurones.
@en
Neuroprotective effects of ato ...... in primary cortical neurones.
@nl
type
label
Neuroprotective effects of ato ...... in primary cortical neurones.
@en
Neuroprotective effects of ato ...... in primary cortical neurones.
@nl
prefLabel
Neuroprotective effects of ato ...... in primary cortical neurones.
@en
Neuroprotective effects of ato ...... in primary cortical neurones.
@nl
P2093
P2860
P50
P1476
Neuroprotective effects of ato ...... in primary cortical neurones.
@en
P2093
Heide Hörtnagl
Julian Bösel
Klaus B Fink
Matthias Endres
Michael Synowitz
Pierre Chryso Djoufack
P2860
P304
P356
10.1111/J.1471-4159.2004.02980.X
P407
P577
2005-03-01T00:00:00Z